Peer-reviewedCC BY 4.0Frontiers in Endocrinology
Editorial: Unveiling the complexity of neuroendocrine neoplasms: biomarkers, classification, and translational perspectives
- 1National Center for Drug Research and Evaluation, National Institute of Health (ISS)
- 2Neuroendocrine Tumor Unit, Department of Medicine, Surgery and Pharmacy, University of Sassari
- 3Endocrine Unit, Azienda Ospedaliero-Universitaria (AOU) of Sassari
Related
- Autophagy in Pituitary Neuroendocrine Tumors (PitNETs): Molecular Mechanisms, Secretory Homeostasis, Therapeutic Resistance, and Translational Perspectives
- Circulating biomarkers in the diagnosis and management of neuroendocrine neoplasms
- IASLC Update on Classification of Pulmonary Neuroendocrine Neoplasms
- Advances in Somatostatin Receptor-Targeting Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors: Biological Rationale, Combination Strategies, and Clinical Perspectives.
- Diagnostic Assessment of Tamoxifen-Associated Endometrial Pathology: A Narrative Review of Biomarkers, Risk Models, and Translational Gaps
BibTeX
@article{salvia2026editorial,
title = {{Editorial: Unveiling the complexity of neuroendocrine neoplasms: biomarkers, classification, and translational perspectives}},
author = {Anna La Salvia and Giuseppe Fanciulli},
journal = {Frontiers in Endocrinology},
year = {2026},
month = oct,
doi = {10.3389/fendo.2026.2030369},
url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.2030369/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Editorial: Unveiling the complexity of neuroendocrine neoplasms: biomarkers, classification, and translational perspectives
AU - Anna La Salvia
AU - Giuseppe Fanciulli
PY - 2026
DA - 2026/10/28
JO - Frontiers in Endocrinology
DO - 10.3389/fendo.2026.2030369
UR - https://www.frontiersin.org/articles/10.3389/fendo.2026.2030369/full
SN - 1664-2392
ER -